AAAAAA
Results: 1-25/53
Authors:
LIU JW
HADJOKAS N
MOSLEY B
ESTROV Z
SPENCE MJ
VESTAL RE
Citation: Jw. Liu et al., ONCOSTATIN M-SPECIFIC RECEPTOR EXPRESSION AND FUNCTION IN REGULATING CELL-PROLIFERATION OF NORMAL AND MALIGNANT MAMMARY EPITHELIAL-CELLS, Cytokine, 10(4), 1998, pp. 295-302
Authors:
DAI RK
ZHAI SP
WEI XX
PINCUS MR
VESTAL RE
FRIEDMAN FK
Citation: Rk. Dai et al., INHIBITION OF HUMAN CYTOCHROME-P450 1A2 BY FLAVONES - A MOLECULAR MODELING STUDY, Journal of protein chemistry, 17(7), 1998, pp. 643-650
Authors:
WINGETT DG
VESTAL RE
FORCIER K
HADJOKAS N
NIELSON CP
Citation: Dg. Wingett et al., CD40 IS FUNCTIONALLY EXPRESSED ON HUMAN BREAST CARCINOMAS - VARIABLE INDUCIBILITY BY CYTOKINES AND ENHANCEMENT OF FAS-MEDIATED APOPTOSIS, Breast cancer research and treatment, 50(1), 1998, pp. 27-36
Authors:
ZHAI S
DAI RK
FRIEDMAN FK
VESTAL RE
Citation: S. Zhai et al., COMPARATIVE INHIBITION OF HUMAN CYTOCHROMES P450 1A1 AND 1A2 BY FLAVONOIDS, Drug metabolism and disposition, 26(10), 1998, pp. 989-992
Authors:
ZHAI SP
DAI RK
WEI XX
FRIEDMAN FK
VESTAL RE
Citation: Sp. Zhai et al., INHIBITION OF METHOXYRESORUFIN DEMETHYLASE ACTIVITY BY FLAVONOIDS IN HUMAN LIVER-MICROSOMES, Life sciences (1973), 63(8), 1998, pp. 119-123
Authors:
VESTAL RE
Citation: Re. Vestal, THE CLINICAL PHARMACOLOGIST - AN ENDANGERED SPECIES, Clinical pharmacology and therapeutics, 64(5), 1998, pp. 471-476
Authors:
MONTAMAT SC
VESTAL RE
Citation: Sc. Montamat et Re. Vestal, THEOPHYLLINE DOES NOT ALTER CARDIOVASCULAR FUNCTION IN AN AGE-DEPENDENT MANNER, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 62-62
Authors:
DAI R
WEI X
ZHAI S
FRIEDMAN FK
VESTAL RE
Citation: R. Dai et al., A COMPUTER MODELING STUDY OF P450 1A2 INHIBITION BY CLASS 1B ANTIARRHYTHMICS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 74-74
Authors:
ZHAI S
DAI R
FRIEDMAN FK
VESTAL RE
Citation: S. Zhai et al., DIFFERENTIAL INHIBITION BY FLAVONOIDS OF HUMAN P450 1A1 AND 1A2, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 75-75
Authors:
ZHAI S
KUNZE KL
LOI CM
VESTAL RE
Citation: S. Zhai et al., EVALUATION OF A MODEL FOR PREDICTION OF DECREASED THEOPHYLLINE CLEARANCE BY INDIVIDUAL AND COMBINED INHIBITORS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 104-104
Authors:
LIU JW
ZHANG YL
SPENCE MJ
VESTAL RE
WALLACE PM
GRASS DS
Citation: Jw. Liu et al., LIVER LDL RECEPTOR MESSENGER-RNA EXPRESSION IS DECREASED IN HUMAN APOE CETP DOUBLE TRANSGENIC MICE AND IS REGULATED BY DIET AS WELL AS THE CYTOKINE ONCOSTATIN-M/, Arteriosclerosis, thrombosis, and vascular biology, 17(11), 1997, pp. 2948-2954
Authors:
LIU JW
SPENCE MJ
WALLACE PM
FORCIER K
HELLSTROM I
VESTAL RE
Citation: Jw. Liu et al., ONCOSTATIN M-SPECIFIC RECEPTOR MEDIATES INHIBITION OF BREAST-CANCER CELL-GROWTH AND DOWN-REGULATION OF THE C-MYC PROTOONCOGENE, Cell growth & differentiation, 8(6), 1997, pp. 667-676
Authors:
CUSACK BJ
YOUNG SP
VESTAL RE
OLSON RD
Citation: Bj. Cusack et al., AGE-RELATED PHARMACOKINETICS OF DAUNORUBICIN AND DAUNORUBICINOL FOLLOWING INTRAVENOUS BOLUS DAUNORUBICIN ADMINISTRATION IN THE RAT, Cancer chemotherapy and pharmacology, 39(6), 1997, pp. 505-512
Authors:
KORRAPATI MR
SORKIN JD
ANDRES R
MULLER DC
LOI CM
VESELL ES
VESTAL RE
Citation: Mr. Korrapati et al., ACETYLATOR PHENOTYPE IN RELATION TO AGE AND GENDER IN THE BALTIMORE LONGITUDINAL-STUDY OF AGING, Journal of clinical pharmacology, 37(2), 1997, pp. 83-91
Authors:
LOI CM
PARKER BM
CUSACK BJ
VESTAL RE
Citation: Cm. Loi et al., AGING AND DRUG-INTERACTIONS .3. INDIVIDUAL AND COMBINED EFFECTS OF CIMETIDINE AND CIPROFLOXACIN ON THEOPHYLLINE METABOLISM IN HEALTHY MALE AND FEMALE NONSMOKERS, The Journal of pharmacology and experimental therapeutics, 280(2), 1997, pp. 627-637
Authors:
LIU JW
STREIFF R
ZHANG YL
VESTAL RE
SPENCE MJ
BRIGGS MR
Citation: Jw. Liu et al., NOVEL MECHANISM OF TRANSCRIPTIONAL ACTIVATION OF HEPATIC LDL RECEPTORBY ONCOSTATIN M, Journal of lipid research, 38(10), 1997, pp. 2035-2048
Authors:
VESTAL RE
CALABRESI P
Citation: Re. Vestal et P. Calabresi, GERIATRIC CLINICAL PHARMACOLOGIST AND MEDICAL ONCOLOGIST - A NEW PARTNERSHIP, Clinical pharmacology and therapeutics, 62(4), 1997, pp. 361-364
Authors:
GAMBLIEL HA
CUSACK BJ
VESTAL RE
FORREST GL
OLSON RD
Citation: Ha. Gambliel et al., CARBONYL REDUCTASE METABOLIZES DAUNORUBICIN (D1) TO C-13 HYDROXY METABOLITE, DAUNORUBICINOL (D2), IN HEART, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 87-87
Authors:
SPENCE MJ
VESTAL RE
LIU JW
Citation: Mj. Spence et al., ONCOSTATIN M-MEDIATED TRANSCRIPTIONAL SUPPRESSION OF THE C-MYC GENE IN BREAST-CANCER CELLS, Cancer research, 57(11), 1997, pp. 2223-2228
Authors:
VESTAL RE
Citation: Re. Vestal, AGING AND PHARMACOLOGY, Cancer, 80(7), 1997, pp. 1302-1310
Authors:
CUSACK BJ
MUSHLIN PS
JOHNSON CJ
VESTAL RE
OLSON RD
Citation: Bj. Cusack et al., AGING INCREASES THE CARDIOTOXICITY OF DAUNORUBICIN AND DAUNORUBICINOLIN THE RAT, The journals of gerontology. Series A, Biological sciences and medical sciences, 51(5), 1996, pp. 376-384
Authors:
MONTAMAT SC
OLSON RD
MUDUMBI RV
VESTAL RE
Citation: Sc. Montamat et al., AGE-RELATED CHARACTERIZATION OF ATRIAL ADENOSINE A(1) RECEPTOR ACTIVATION - DIRECT EFFECTS ON CHRONOTROPIC AND INOTROPIC FUNCTION IN THE FISCHER-344 RAT, The journals of gerontology. Series A, Biological sciences and medical sciences, 51(4), 1996, pp. 239-246
Authors:
BALL SK
VESTAL RE
MUDUMBI RV
Citation: Sk. Ball et al., AGE-RELATED EFFECTS OF ADENOSINE A(2) RECEPTOR (A(2)R) AGONISTS IN FISCHER-344 (F344) RAT ARTERIES, The FASEB journal, 10(3), 1996, pp. 385-385
Authors:
MUDUMBI RV
MENDENHALL WA
OLSON RD
VESTAL RE
Citation: Rv. Mudumbi et al., INVOLVEMENT OF ADENOSINE A(1) RECEPTOR (A(1)R) ACTIVATION DURING HYPOXIC (H) PRECONDITIONING (PC) IN ISOLATED RAT LEFT ATRIA (LA), The FASEB journal, 10(3), 1996, pp. 1845-1845
Authors:
KAPICKA CL
MONTAMAT SC
OLSON RD
MUDUMBI RV
VESTAL RE
Citation: Cl. Kapicka et al., SPECIES COMPARISON OF ADENOSINE A(1) RECEPTORS (A(1)R) IN MAMMALIAN ATRIAL AND VENTRICULAR MYOCARDIUM, The FASEB journal, 10(3), 1996, pp. 2480-2480